FIG 2.
Inhibition of carD promoter transcription by CarD is reduced by substitutions in CarD. (A) In vitro transcription of the carD promoter with 20 nM RNAP without CarD or with wild-type or W91A, W91L, or Q31A/I33A/R53A triple-mutant CarD (1,280 nM). (B) Transcription from the carD promoter in the presence of wild-type or mutant CarD relative to its transcription in the absence of CarD from experiments like that shown in panel A; error bars indicate range from 2 assays.
